Moderna is applying for regulatory approval for its RSV vaccine, which it says has shown to be effective against the respiratory virus.
Share:
More In Science
Facebook Froze as Anti-Vaccine Comments Swarmed Users
Last spring, as false claims about vaccine safety threatened to undermine the world's response to COVID-19, researchers at Facebook found they could reduce vaccine misinformation by tweaking how vaccine posts show up on users' newsfeeds.
The Stone Age Immersive Exhibit Wants to Change the Cannabis Narrative
New York City's first immersive cannabis experience, The Stone Age, is seeking to change the narrative about cannabis, just in time for legalization.
UN: Greenhouse Gas Levels Hit a New Record, Cuts Fall Short
The U.N. weather agency says greenhouse gas concentrations hit a new record high last year and increased at a faster rate than the annual average for the last decade.
Moderna Says Its Low-Dose COVID Shot Works for Kids 6 to 11
Moderna says its low-dose COVID-19 vaccine is safe and appears to work in 6- to 11-year-olds.
U.S. Salmonella Outbreak Tied to Onions Sickens More Than 650
U.S. health officials say a salmonella outbreak tied to onions has sickened more than 650 people in 37 states.
Pig-to-Human Transplants Come a Step Closer With New Test
Scientists have temporarily attached a pig’s kidney to a human body and watched it begin to work.
NFL, Players Agree to End 'Race-Norming' in $1B Settlement
The NFL and lawyers for thousands of retired NFL players have reached an agreement to end race-based adjustments in dementia testing in the $1 billion settlement of concussion claims.
FDA OKs Mixing COVID Vaccines; Backs Moderna, J&J Boosters
U.S. regulators are extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine.
White House Details Plans to Vaccinate 28M Children Age 5-11
Kids aged 5 to 11 will soon be able to get a COVID-19 shot at their pediatrician’s office, local pharmacy and potentially even their school.
